{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:35:59Z","timestamp":1789526159535,"version":"build-2803163510"},"reference-count":44,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Beijing Municipal Administration of Hospitals Incubating Program","award":["PX2023006"],"award-info":[{"award-number":["PX2023006"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Data on the outcomes of restrictive cardiomyopathy (RCM) are limited, when the condition is complicated with arrhythmia. This study was designed to investigate the prevalence of atrial fibrillation (AF), ventricular tachycardia (VT) and bradycardia (BC) and their impact on adverse outcomes (intra-cardiac thrombus, stroke and systematic embolism [SSE], heart failure and death) of RCM. Methods and Results: The retrospective cohort study used data collected from the Beijing Municipal Health Commission Information Center (BMHCIC) database from 1 January 2010 to 31 December 2020. There were 745 (64.9%) patients with AF, 117 (10.2%) patients with VT and 311 (27.1%) patients with bradycardia. The presence of AF was associated with an increased risk of SSE (adjusted HR:1.37, 95%CI:1.02\u20131.83, p = 0.04) and heart failure (aHR:1.36, 95%CI:1.17\u20131.58, p &lt; 0.001). VT was associated with an increased risk of intracardiac thrombus (aHR:2.34, 95%CI:1.36\u20134.01, p = 0.002) and death (aHR:2.07, 95%CI:1.19\u20133.59, p = 0.01). Bradycardia did not increase the adverse outcomes in RCM. The results remained consistent and steady when AF, VT and bradycardia were adjusted as competing factors. Conclusions: Cardiac arrhythmia are highly prevalent and associated with adverse outcomes in patients with RCM. AF and VT are more likely to be associated with intracardiac thrombosis, and the presence of AF increased the risk of SSE and HF. The presence of VT increased the risk of death.<\/jats:p>","DOI":"10.3390\/jcm12031236","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T01:35:13Z","timestamp":1675647313000},"page":"1236","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Prevalence and Impact of Arrhythmia on Outcomes in Restrictive Cardiomyopathy\u2014A Report from the Beijing Municipal Health Commission Information Center (BMHCIC) Database"],"prefix":"10.3390","volume":"12","author":[{"given":"Haiyan","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Neurology and Psychiatry, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitong","family":"Liu","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Beijing Tongren Hospital, Capital Medical University, Beijing 100051, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Beijing Tongren Hospital, Capital Medical University, Beijing 100051, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianpeng","family":"Zheng","sequence":"additional","affiliation":[{"name":"Beijing Municipal Health Commission Information Center, Beijing 100034, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Lu","sequence":"additional","affiliation":[{"name":"Beijing Municipal Health Commission Information Center, Beijing 100034, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University, Liverpool Heart & Chest Hospital, Liverpool L14 3PE, UK"},{"name":"Department of Clinical Medicine, Aalborg University, DK-9100 Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Bai","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Beijing Tongren Hospital, Capital Medical University, Beijing 100051, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/HCO.0b013e32832a1d2e","article-title":"Restrictive cardiomyopathy","volume":"24","author":"Mogensen","year":"2009","journal-title":"Curr. Opin. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: A position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1056\/NEJM199701233360407","article-title":"Restrictive cardiomyopathy","volume":"336","author":"Kushwaha","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e001780","DOI":"10.1161\/CIRCGENETICS.117.001780","article-title":"Novel Mutation in FLNC (Filamin C) Causes Familial Restrictive Cardiomyopathy","volume":"10","author":"Tucker","year":"2017","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.jacc.2016.01.076","article-title":"Constrictive Pericarditis Versus Restrictive Cardiomyopathy?","volume":"67","author":"Garcia","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2217\/fca.11.18","article-title":"Constrictive pericarditis and restrictive cardiomyopathy in the modern era","volume":"7","author":"Mookadam","year":"2011","journal-title":"Future Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.CIR.61.6.1206","article-title":"Clinical profile of restrictive cardiomyopathy","volume":"61","author":"Benotti","year":"1980","journal-title":"Circulation"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0025-6196(12)61043-X","article-title":"Restrictive cardiomyopathy associated with the eosinophilia-myalgia syndrome","volume":"69","author":"Berger","year":"1994","journal-title":"Mayo Clin. Proc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0002-9149(76)80001-X","article-title":"Cardiac amyloidosis, contrictive pericarditis and restrictive cardiomyopathy","volume":"38","author":"Meaney","year":"1976","journal-title":"Am. J. Cardiol."},{"key":"ref_10","first-page":"123","article-title":"Pathophysiology and differential diagnosis of restrictive cardiomyopathy","volume":"19","author":"Shabetai","year":"1988","journal-title":"Cardiovasc. Clin."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/01.CIR.70.2.165","article-title":"Idiopathic restrictive cardiomyopathy","volume":"70","author":"Siegel","year":"1984","journal-title":"Circulation"},{"key":"ref_12","first-page":"2347","article-title":"Inherited cardiomyopathies","volume":"78","author":"Towbin","year":"2014","journal-title":"Circ. J. Off. J. Jpn. Circ. Soc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/CIRCRESAHA.117.310982","article-title":"Restrictive Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy","volume":"121","author":"Muchtar","year":"2017","journal-title":"Circ. Res."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Cimiotti, D., Budde, H., Hassoun, R., and Jaquet, K. (2021). Genetic Restrictive Cardiomyopathy: Causes and Consequences-An Integrative Approach. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22020558"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Brodehl, A., and Gerull, B. (2022). Genetic Insights into Primary Restrictive Cardiomyopathy. J. Clin. Med., 11.","DOI":"10.20944\/preprints202203.0265.v1"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1161\/01.CIR.101.21.2490","article-title":"Clinical profile and outcome of idiopathic restrictive cardiomyopathy","volume":"101","author":"Ammash","year":"2000","journal-title":"Circulation"},{"key":"ref_17","first-page":"969","article-title":"Restrictive cardiomyopathy with right-sided dominant heart failure after sinus conversion from atrial fibrillation: Case report","volume":"67","author":"Sasaki","year":"2003","journal-title":"Circ. J. Off. J. Jpn. Circ. Soc."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/hrt.63.2.114","article-title":"Familial restrictive cardiomyopathy with atrioventricular block and skeletal myopathy","volume":"63","author":"Fitzpatrick","year":"1990","journal-title":"Br. Heart J."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Ciarambino, T., Menna, G., Sansone, G., and Giordano, M. (2021). Cardiomyopathies: An Overview. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22147722"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"18799","DOI":"10.1038\/s41598-022-20042-9","article-title":"Prevalence, incidence and mortality of hypertrophic cardiomyopathy based on a population cohort of 21.9 million in China","volume":"12","author":"Bai","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.2337\/dc21-0342","article-title":"Incidence of Type 1 Diabetes May Be Underestimated in the Chinese Population: Evidence From 21.7 Million People between 2007 and 2017","volume":"44","author":"Liu","year":"2021","journal-title":"Diabetes Care"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","article-title":"2017 aha\/acc\/hrs guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the american college of cardiology\/american heart association task force on clinical practice guidelines and the heart rhythm society","volume":"72","author":"Stevenson","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_23","first-page":"e240","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1002\/ehf2.12854","article-title":"Atrial fibrillation, anticoagulation management and risk of stroke in the Cardiomyopathy\/Myocarditis registry of the EURObservational Research Programme of the European Society of Cardiology","volume":"7","author":"Caforio","year":"2020","journal-title":"ESC Heart Fail."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","article-title":"Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: A position statement of the ESC working group on myocardial and pericardial diseases","volume":"37","author":"Pinto","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(16)31321-6","article-title":"Hypertrophic obstructive cardiomyopathy","volume":"389","author":"Veselka","year":"2017","journal-title":"Lancet"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2016.08.050","article-title":"Differentiation of Constriction and Restriction: Complex Cardiovascular Hemodynamics","volume":"68","author":"Geske","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e021970","DOI":"10.1161\/JAHA.121.021970","article-title":"Atrial Fibrillation in Patients With Cardiomyopathy: Prevalence and Clinical Outcomes from Real-World Data","volume":"10","author":"Buckley","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_30","first-page":"360","article-title":"Right ventricular endomyocardial fibrosis presenting with ventricular tachycardia and apical thrombus\u2014An interesting presentation","volume":"9","author":"Aggarwal","year":"2009","journal-title":"Indian Pacing Electrophysiol. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ejhf.1461","article-title":"Heart failure in cardiomyopathies: A position paper from the Heart Failure Association of the European Society of Cardiology","volume":"21","author":"Polovina","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"ref_32","first-page":"24","article-title":"Endomyocardial fibrosis presented by ventricular tachycardia: Case report","volume":"71","author":"Abdelnabi","year":"2019","journal-title":"Egypt. Heart J. (EHJ) Off. Bull. Egypt. Soc. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.amjcard.2009.05.040","article-title":"Frequencies and types of arrhythmias in patients with systemic light-chain amyloidosis with cardiac involvement undergoing stem cell transplantation on telemetry monitoring","volume":"104","author":"Goldsmith","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1046\/j.1460-9592.2001.01228.x","article-title":"Holter monitoring in AL amyloidosis: Prognostic implications","volume":"24","author":"Palladini","year":"2001","journal-title":"Pacing Clin. Electrophysiol. PACE"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.hrthm.2013.10.026","article-title":"Implantable cardioverter-defibrillator placement in patients with cardiac amyloidosis","volume":"11","author":"Varr","year":"2014","journal-title":"Heart Rhythm"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jacep.2020.01.004","article-title":"Management of Arrhythmias in Cardiac Amyloidosis","volume":"6","author":"Giancaterino","year":"2020","journal-title":"JACC. Clin. Electrophysiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/hrt.2009.190405","article-title":"Amyloid diseases of the heart: Assessment, diagnosis, and referral","volume":"97","author":"Dubrey","year":"2011","journal-title":"Heart"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"s30","DOI":"10.7861\/clinmedicine.18-2-s30","article-title":"Cardiac amyloidosis","volume":"18","author":"Hawkins","year":"2018","journal-title":"Clin. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e006619","DOI":"10.1161\/CIRCHEARTFAILURE.119.006619","article-title":"Baseline ECG Features and Arrhythmic Profile in Transthyretin Versus Light Chain Cardiac Amyloidosis","volume":"13","author":"Cappelli","year":"2020","journal-title":"Circ. Heart Fail."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/STROKEAHA.109.567800","article-title":"Premature ventricular complexes and the risk of incident stroke: The Atherosclerosis Risk In Communities (ARIC) Study","volume":"41","author":"Agarwal","year":"2010","journal-title":"Stroke"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ijcard.2013.03.058","article-title":"Stroke and ventricular arrhythmias","volume":"168","author":"Koppikar","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/STROKEAHA.109.574426","article-title":"\u2018Where there\u2019s smoke\u2026\u2019: Are premature ventricular complexes a new risk factor for stroke?","volume":"41","author":"Worthington","year":"2010","journal-title":"Stroke"},{"key":"ref_43","first-page":"74","article-title":"The role of 3D and speckle tracking echocardiography in cardiac amyloidosis: A case report","volume":"18","author":"Nucci","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1253\/jcj.57.928","article-title":"Restrictive cardiomyopathy with complete atrioventricular block and distal myopathy with rimmed vacuoles","volume":"57","author":"Ishiwata","year":"1993","journal-title":"Jpn. Circ. J."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/3\/1236\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:23:38Z","timestamp":1760120618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/3\/1236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,3]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["jcm12031236"],"URL":"https:\/\/doi.org\/10.3390\/jcm12031236","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,3]]}}}